Ponatinib induced improvement of cutaneous lesions associated to accelerated phase of Ph-positive chronic myeloid leukemia by Massimo Breccia, Gioia Colafigli, Luisa Quattrocchi, elisabetta abruzzese, giuliana alimena

Subjects: “…CML, ponatinib, extramedullary localization…”
Get full text

Significance of Clinical-Pathological Correlation in Ponatinib Reactions by Judith Monserrat Corona Herrera, Fanny Carolina López Jiménez, Verónica Monserrat Díaz Sánchez, Betzabé Quiles Martínez, Marcela Saeb Lima, Silvia Méndez Flores

Subjects: “…Ponatinib…”
Get full text

Ponatinib alleviates non-alcoholic steatohepatitis through TFEB-mediated autophagy by Zhuomiao Lin, Meiqing Yang, Xihui Yu, Guozhu Tan, Jiahong Zhong

Subjects: “…ponatinib…”
Get full text

Gossypol enhances ponatinib's cytotoxicity against human hepatocellular carcinoma cells by involving cell cycle arrest, p-AKT/LC3II/p62, and Bcl2/caspase-3 pathways by Hadeel H. Elkattan, Alaa E. Elsisi, Naglaa M. El-Lakkany

Subjects: Get full text

The new HFA/ICOS risk assessment tool to identify patients with chronic myeloid leukaemia at high risk of cardiotoxicity by Daniela Di Lisi, Cristina Madaudo, Giulia Alagna, Marco Santoro, Ludovico Rossetto, Sergio Siragusa, Giuseppina Novo

Subjects: Get full text

Chromatographic analysis of ponatinib and its impurities: method development, validation, and identification of new degradation product by Jing Wang, Yonghong Zhu, Jisu Qin, Wenyi Wu, Rongrong Huang, Liangliang Cai

Subjects: “…ponatinib…”
Get full text

Successful treatment of two cases with Philadelphia-chromosome positive acute lymphoblastic leukemia who relapsed after allogeneic stem cell transplantation and the treatments with... by Takayoshi Tachibana, Masatsugu Tanaka, Yuma Noguchi, Yuho Najima, Daichi Sadato, Yuka Harada, Yotaro Tamai, Noriko Doki, Hideaki Nakajima

Subjects: Get full text

Arterial Occlusive Events in a Patient With Chronic Myeloid Leukemia Treated With Ponatinib by Osamu Imataki, Makiko Uemura

Subjects: Get full text

DRUG THERAPY IN THE PROGRESSED CML PATIENT WITH MULTI-TKI FAILURE by Ibrahim C. Haznedaroglu

Subjects: “…Chronic myeloid leukemia (CML), tyrosine kinase inhibitor (TKI) resistance, Bosutinib, Ponatinib, Dasatinib, Nilotinib, Omacetaxine mepussecinate…”
Get full text

Ponatinib vs. asciminib in post–second-generation tyrosine kinase inhibitor therapy for chronic-phase chronic myeloid leukemia: a matching-adjusted indirect comparison by Valentin Garcia-Gutierrez, Fei Huang, Ajibade Ashaye, Mehul Dalal, Victor Laliman-Khara, Massimo Breccia, Megan Rutherford, Hoora Moradian, Petros Patos, Elias Joseph Jabbour

Subjects: Get full text